On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Vertex Pharmaceuticals (Europe) Limited's own share of each project, not the project's full budget.
- Horizon 2020€0 · 2 projects
- Horizon Europe€0 · 1 project
Projects
3 EU-funded projects, newest first. Each links to the official record.
- CATALOOPAssociated partner
Closing the loop in stereoselective catalysis with data-driven approaches
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- TransQSTPartner
Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
- RADIATEPartner
Radiation Innovations for Therapy and Education
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 3 shared projects
- Universiteit MaastrichtNetherlands · 2 shared projects
- Universiteit LeidenNetherlands · 1 shared project
- Universitat WienAustria · 1 shared project
- European Molecular Biology LaboratoryGermany · 1 shared project
- Rijksuniversiteit GroningenNetherlands · 1 shared project
- University College Dublin, National University of Ireland, DublinIreland · 1 shared project
- Rheinisch-Westfaelische Technische Hochschule AachenGermany · 1 shared project
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
- Technische Universitaet DresdenGermany · 1 shared project
- Technion - Israel Institute of TechnologyIsrael · 1 shared project
- Eberhard Karls Universitaet TuebingenGermany · 1 shared project
- Universite de GeneveSwitzerland · 1 shared project
- Universite Catholique de LouvainBelgium · 1 shared project
- The University of LiverpoolUnited Kingdom · 1 shared project
- Universidad de Santiago de CompostelaSpain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- adverse drug reactions
- cardiac arrhythmia
- catalysis
- drug discovery
- drug safety
- immunology
- nuclear medicine
- oncology
- toxicology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.